# Olmesartan Medoxomil in Diabetes Mellitus

> **NCT00185159** · PHASE3 · COMPLETED · sponsor: **Sankyo Pharma Gmbh** · enrollment: 4449 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2
- Cardiovascular Disease
- Kidney Disease

## Interventions

- **DRUG:** Olmesartan medoxomil
- **DRUG:** Placebo Tablets

## Key facts

- **NCT ID:** NCT00185159
- **Lead sponsor:** Sankyo Pharma Gmbh
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 4449 (ACTUAL)
- **Last updated:** 2010-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00185159

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00185159, "Olmesartan Medoxomil in Diabetes Mellitus". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00185159. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*